CROs/Service Providers

genae buys e-novex

Wednesday, January 28, 2015 11:56 AM

genae, a global CRO and services provider, has acquired e-novex, a provider of electronic data tools for medical research. Both companies are based in Antwerp, Belgium.

More... »

Theorem Clinical Research

Covance launches new solution to bridge preclinical to clinical development

Monday, January 26, 2015 12:48 PM

Princeton, N.J.-based CRO Covance has introduced Covance Early Phase Development Solutions, a multi-disciplined approach to early drug development, partnership and continuity to generate greater value in asset development and achieve accelerated delivery timelines.

More... »

Quest Diagnostics

Novotech expands operation in Hong Kong

Monday, January 26, 2015 12:46 PM

Sydney, Australia-based Novotech has expanded its Hong Kong operation into a permanent office with more staff to meet the increasing demand in the pharmaceutical market for clinical research.

More... »

ERT supports improved healthcare delivery in low-resource areas

Monday, January 26, 2015 12:42 PM

ERT, a global solution provider for patient safety and efficacy endpoint data collection based in Wilmington, N.C., is continuing its outreach program, through which ERT provides equipment, financial support and other resources to support quality healthcare delivery throughout the world.

More... »

KCR launches CTMS platform in cooperation with Quadratek

Monday, January 26, 2015 12:37 PM

KCR, a CRO operating across 19 European countries and in the U.S., is developing an innovative clinical trial data platform based on the Clincase electronic data capture (EDC) and clinical data management (CDM) software by Quadratek Data Service.

More... »

med fusion expands solid tumor profiling services

Thursday, January 22, 2015 12:20 PM

med fusion, an integrated Molecular Center of Excellence and clinical trials service organization headquartered in Lewisville, Texas, has released its solid tumor molecular profiling testing services (SEQ) enhanced by next generation sequencing (NGS) technology. The introduction of NGS will further enable physicians to interrogate their patient’s tumor at the molecular level in order to develop a personalized treatment plan according to the genetic makeup of their specific tumor.

More... »

PPD expands GMP laboratory in Ireland

Wednesday, January 21, 2015 12:59 PM

Pharmaceutical Product Development (PPD), a global CRO based in Wilmington, N.C., has expanded its good manufacturing practices (GMP) operations in Athlone, Ireland, by adding a new, state-of-the-art laboratory for cell-based assays to its existing portfolio of services at the facility. The new lab provides GMP bioassay testing with dedicated areas to support cell culture activities with multiple assay endpoint expertise.

More... »

WCCT Global, NIAID to collaborate on influenza challenge research

Friday, January 16, 2015 12:26 PM

CRO WCCT Global, headquartered in Southern California, is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) for influenza challenge research. With the construction of WCCT Global's influenza challenge facility in Costa Mesa, Calif., the CRO has the capability to conduct virus challenge clinical trials in North America.

More... »

Cromsource supports Italian Cystic Fibrosis Society’s clinical research training initiative

Thursday, January 15, 2015 01:19 PM

Cromsource, an international CRO, is delivering several modules of a training course on clinical research best practice organized by the SIFC (Italian Cystic Fibrosis Society). The course commenced in December 2014 and will complete in February 2015.

More... »

Covance to vote on proposed acquisition by LabCorp Feb. 18

Tuesday, January 13, 2015 08:00 AM

CRO Covance has set a date for a special meeting of its stockholders to consider and vote on the previously announced proposed acquisition of Covance by Laboratory Corporation of America Holdings (LabCorp) and certain other related matters. The special meeting will be held Feb. 18, at 8 a.m., in Princeton, N.J.

More... »


March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs